How one New Jersey dentist changed the practice forever

Shortly after graduating from the New York School of Dentistry, AviWeisfogel founded his first practice. Old Bridge Dental quickly rose to prominence among its Central New Jersey clientele. With a puritan work ethic, Dr. Weisfogel built the practice into a thriving beacon of dental excellence for the whole state. But this project was just one of many for the industrious odontology prodigy. In his spare time, he was pursuing a variety of studies, one of which would come to occupy an increasingly dominant space in his head.

It was thusly that Dr. Weisfogel began down the path to epiphany. Why, he wondered, are dentists so narrowly constrained in their practice? If dentists were more versatile diagnosticians, he reasoned, could they make a sizable impact on disease processes unrelated to dentistry? To learn more: https://aviweisfogel.wordpress.com/ click here.

Dr. Weisfogel knew that, for a large subset of patients, dentists were the only health care medical professionals who they were likely to see over the course of years to decades. This is because of the nature of dental ailments. If someone wishes, postponing a routine physical or a colonoscopy is easy enough to do. In fact, most of the time, it can be postponed indefinitely, without apparent consequence.

However, any patient who attempts to postpone seeing a dentist for an abscessed third molar will quickly get a participatory lesson in the limits of human pain tolerance. Likewise, even chipped front teeth can ruin the week – and smile – of just about anyone, outside of professional combat sportsmen. For this reason, Dr. Wiesfogel concluded that dentists could make a huge difference in the cure rates for deadly diseases that are often times hopeless in the late stages but highly treatable in the earliest ones.

After considerable research, Dr. Weisfogel learned sleep apnea is one of the most underdiagnosed and socially costly diseases in the United States. He set about to improve the diagnosis and clinical course for this insidious killer.

In 2011, Dr. Weisfogel founded Dental Sleep Masters, a clinical program dedicated to teaching dentists how to accurately diagnose and treat sleep apnea. Over the last few years, the program has been a runaway success, graduating thousands of dentists and creating the field of sleep dentistry.

Clay Siegall Is Transforming the Healthcare Sector

Cancer is considered to be one of the deadliest diseases in the world today. The disease is killing people from all walks of life every day. Although many organizations and governments are working hard to analysis and research about the serious illness, a cure for the disease at the late stages has not been found yet.

Clay Siegall is one of the most influential individuals in the cancer world. The internationally recognized scientist has done a lot for the people living with cancer. Siegall has invested a lot of resources and time to conduct research and come up with therapies to cure different types of cancers. The main aim of the successful scientist is to eradicate cancer from the world. At the moment, Clay Siegall serves as the president and chairman of Seattle Genetics. Clay founded the pharmaceutical company, and he has done a lot to make sure that the institution reaches its goals.

Since its establishment in the international market, Seattle Genetics has developed some effective antibody therapies for the people who have cancer. The treatment from the company has saved the lives of many people with the disease. Under the leadership of Clay Siegall, Seattle Genetics has earned the trust of many.

Clay Siegall is believed to have studied his zoology course at the prestigious Maryland University. He, however, felt that he needed a Ph.D. in Genetics, and this forced him to study at the Washington University. His career has been focused in cancer research. At the moment, the businessman is considered to be one of the most successful scientists in the oncology division.

As the president of Seattle Genetics, Clay Siegall’s primary responsibility is to ensure that the company achieves its goals. Siegall has secured the funds needed for the expansion required in the organization since it was established in the year 1998. Not long ago, he helped the company to raise over three million dollars to improve cancer research. The drug from the company, known as ADCETRIC has already found its way on the international platform, and it is currently used in sixty-six nations in the world.